Finance

Beta
Lists
COHANCE:NSE
Cohance Lifesciences Ltd
₹426.80
+0.79%
(+3.35) 1D
Jun 12, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for COHANCE...
Open
₹428.95
High
₹434.95
Low
₹422.70
Mkt. cap
163.28B
Avg. vol.
2.11M
Volume
350.79K
P/E ratio
91.20
52-wk high
₹1,121.15
52-wk low
₹266.70
EPS
₹4.68
No. of employees
1K
Open
₹428.95
High
₹434.95
Low
₹422.70
Mkt. cap
163.28B
Avg. vol.
2.11M
Volume
350.79K
P/E ratio
91.20
52-wk high
₹1,121.15
52-wk low
₹266.70
EPS
₹4.68
No. of employees
1K
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to COHANCE in the past 3 months
Sell
Buy
0
Hold
0
Sell
1
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for COHANCE in the last 3 months.
Highest
Current ₹426.80
₹300.00 (-29.71%)
Average
₹300.00 (-29.71%)
Lowest
₹300.00 (-29.71%)
News stories
From sources across the web
About Cohance Lifesciences Ltd
CEO-
Employees1.21K
Founded1989
Headquarters-
SectorPharmaceutical industry
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹0.68 / ₹1.52
-55.51%miss
Revenue / Est. (INR)
6.19B / 5.76B
+7.44%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
5.49B
5.56B
5.45B
6.19B
Cost of goods sold
1.48B
1.41B
1.59B
2.14B
Cost of revenue
1.48B
1.41B
1.59B
2.14B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.33B
1.27B
1.19B
1.29B
Operating expense
3.34B
3.38B
3.37B
3.57B
Total operating expenses
4.82B
4.79B
4.96B
5.72B
Operating income
668.70M
769.30M
484.10M
474.50M
Other non operating income
141.70M
156.00M
61.60M
-18.40M
EBT including unusual items
627.60M
837.70M
406.00M
199.10M
EBT excluding unusual items
708.60M
837.70M
454.60M
364.20M
Income tax expense
163.60M
173.80M
115.80M
116.00M
Effective tax rate
26.07%
20.75%
28.52%
58.26%
Other operating expenses
1.56B
1.67B
1.72B
1.77B
Net income
488.80M
740.80M
367.20M
195.50M
Net profit margin
8.90%
13.33%
6.74%
3.16%
Earnings per share
1.63
1.93
0.55
0.68
Interest and investment income
-
-
-
-
Interest expense
-101.80M
-87.60M
-91.10M
-91.90M
Net interest expenses
-101.80M
-87.60M
-91.10M
-91.90M
Depreciation and amortization charges
451.40M
440.20M
469.40M
512.30M
EBITDA
862.42M
1.23B
677.82M
942.82M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more